Journal of International Oncology››2012,Vol. 39››Issue (12): 907-909.

Previous ArticlesNext Articles

Progression of lobaplatin for cancer

SUN Na, YANG Wen-Yan

  1. ShandongInstitute of Medicine and Health Information, Shandong Academy of Medical Sciences, Jinan 250062, China
  • Online:2012-12-08Published:2012-11-15

Abstract:Lobaplatin isthe third generation platinum drug.Many studies on pharmacodynamics have been confirmed that lobaplatin can block the cell cycle and induce cell apoptosis, and thus inhibits tumor cell proliferation effectively. Lobaplatinis not cross-resistant to cisplatin. Besides, it has good curative effect to various kinds of cancer patients with mild adverse reactions, and the patients are well tolerable to it.

Key words:Neoplasms,font-size: 12pt,mso-font-kerning: 1.0pt,mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-bidi-font-family: 'Times New Roman',mso-bidi-font-size: 14.0pt" lang="EN-US">Pharmacodynamics,font-size: 12pt,mso-font-kerning: 1.0pt,mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-bidi-font-family: 'Times New Roman',mso-bidi-font-size: 14.0pt" lang="EN-US">Clinical research,font-size: 12pt,mso-font-kerning: 1.0pt,mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-bidi-font-family: 'Times New Roman',mso-bidi-font-size: 14.0pt" lang="EN-US">Lobaplatin